Adolescent health briefTreatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic
Keywords
Opioid use disorder
Adolescent
Adolescent health services
Medication for addiction treatment
Medication for opioid use disorder
Insurance
Medicaid
COVID-19
Cited by (0)
Conflicts of interest: Dr. Alexander is past Chair and a current member of FDA’s Peripheral and Central Nervous System Advisory Committee; is a cofounding Principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation; and is a past member of OptumRx’s National P&T Committee. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict-of-interest policies. No other disclosures were reported.
© 2022 Society for Adolescent Health and Medicine. All rights reserved.